Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant Acinetobacter baumannii in Europe, 2019

Euro Surveill. 2020 Nov;25(45):2001735. doi: 10.2807/1560-7917.ES.2020.25.45.2001735.

Abstract

To update information on the epidemiological situation and national capacity for detection, surveillance and containment of carbapenem-resistant Acinetobacter baumannii (CRAb) in Europe, we performed a survey in 37 countries. Nine countries reported regional or inter-regional spread and seven an endemic situation. Laboratories with a reference function, surveillance systems, and a national containment plan for CRAb existed in 30, 23 and eight countries, respectively. A pan-European molecular survey would provide in-depth understanding of the CRAb epidemiology.

Keywords: Acinetobacter baumannii; Europe; Surveillance; Whole Genome Sequencing; carbapenem resistance; laboratory capacity.

MeSH terms

  • Acinetobacter Infections* / drug therapy
  • Acinetobacter Infections* / epidemiology
  • Acinetobacter baumannii* / drug effects
  • Carbapenems* / pharmacology
  • Drug Resistance, Bacterial*
  • Europe / epidemiology
  • Humans
  • Laboratories* / organization & administration

Substances

  • Carbapenems